We are live on ! Find out more
STOK icon

Stoke Therapeutics
STOK

93 hedge funds and large institutions have $2.39B invested in Stoke Therapeutics in 2020 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 32 increasing their positions, 25 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

842% more call options, than puts

Call options by funds: $4.78M | Put options by funds: $507K

106% more capital invested

Capital invested by funds: $1.16B → $2.39B (+$1.23B)

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

45% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 11

28% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 25

6% more funds holding

Funds holding: 88 → 93 (+5)

3.25% more ownership

Funds ownership: 104.19% → 107.44% (+3.2%)

Holders
93
Holders Change
+5
Holders Change %
+5.68%
% of All Funds
1.65%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
16
Increased
32
Reduced
25
Closed
11
Calls
$4.78M
Puts
$507K
Net Calls
+$4.27M
Net Calls Change
+$2.79M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$76.1M
2
Goldman Sachs
Goldman Sachs
New York
+$21.5M
3
BlackRock
BlackRock
New York
+$19.4M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$17.4M
5
ALSV
ATP Life Science Ventures
New York
+$17.2M

Top Sellers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
-$4.58M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$3.44M
3
VOYA Investment Management
VOYA Investment Management
Georgia
-$3.21M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.83M
5
Aviva
Aviva
United Kingdom
-$1.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$2.46M +$1.49M +32,432 +439%
Aviva
27
Aviva
United Kingdom
$2.28M -$1.37M -29,792 -45%
PCM
28
Pinz Capital Management
New York
$2.12M +$1.57M +34,200 New
TD Asset Management
29
TD Asset Management
Ontario, Canada
$1.94M +$415K +9,062 +41%
Invesco
30
Invesco
Georgia
$1.57M +$1.16M +25,329 New
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$1.55M -$22.9K -500 -2%
Two Sigma Investments
32
Two Sigma Investments
New York
$1.54M +$1.14M +24,940 New
BC
33
Birchview Capital
Vermont
$1.24M – – –
MIM
34
Monashee Investment Management
Massachusetts
$1.24M +$917K +20,000 New
Swiss National Bank
35
Swiss National Bank
Switzerland
$1.16M -$142K -3,100 -14%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$1.16M +$15.8K +344 +2%
HS
37
HighVista Strategies
Massachusetts
$1.09M +$26.9K +586 +3%
AllianceBernstein
38
AllianceBernstein
Tennessee
$1.08M -$151K -3,300 -16%
State of Wisconsin Investment Board
39
State of Wisconsin Investment Board
Wisconsin
$1.07M -$101K -2,200 -11%
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$971K +$41.7K +910 +6%
B
41
Bailard
California
$873K +$646K +14,100 New
CS
42
Credit Suisse
Switzerland
$815K +$270K +5,884 +81%
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
$687K – – –
Morgan Stanley
44
Morgan Stanley
New York
$679K +$362K +7,899 +258%
Deutsche Bank
45
Deutsche Bank
Germany
$570K +$113K +2,474 +37%
SFI
46
Susquehanna Fundamental Investments
Pennsylvania
$557K +$412K +8,990 New
EAM
47
Erste Asset Management
Austria
$544K +$422K +9,200 New
DekaBank Deutsche Girozentrale
48
DekaBank Deutsche Girozentrale
Germany
$523K – – –
ProShare Advisors
49
ProShare Advisors
Maryland
$516K +$67.9K +1,482 +22%
Wells Fargo
50
Wells Fargo
California
$497K +$107K +2,330 +41%
1
2
3 4 5

STOK Hedge Fund Activity: Q4 2020 in Review

93 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Stoke Therapeutics (STOK) for Q4 2020, worth a combined $2.39B — up 106% from $1.16B a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new STOK positions and 11 closed out — a net gain of 5 holders — while 32 added to existing stakes and 25 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $76.1M. The largest seller was Cormorant Asset Management, cutting an estimated $4.58M.

  • 93 institutional investors held Stoke Therapeutics (STOK) as of Q4 2020, up from 88 in Q3 2020.
  • Funds reported $2.39B of Stoke Therapeutics stock for Q4 2020, up 106% quarter-over-quarter.
  • 16 funds opened new Stoke Therapeutics positions in Q4 2020 and 11 closed out, a net change of +5 holders.
  • The largest Stoke Therapeutics buyer in Q4 2020 was Fidelity Investments, an estimated $76.1M added.
  • The largest Stoke Therapeutics seller in Q4 2020 was Cormorant Asset Management, an estimated $4.58M sold.

Based on aggregated 13F filings for Q4 2020.